Metropolis Healthcare has informed that the meeting of the Board of Directors of the Company is scheduled on February 04, 2026, inter alia, to consider and approve a) Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2025; and b) Issuance of Bonus Shares in accordance with the applicable provisions and subject to approval of shareholders of the Company.
The above information is a part of company’s filings submitted to BSE.